Fingerprint
Dive into the research topics of 'A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically